Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Foscenvivint in Hemophilia: NCT07681089 Clinical Landscape Report 2026
11 September 2026
NCT07681089 clinical landscape for Hemophilia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Anlotinib Dihydrochloride in Unresectable Hepatocellular Carcinoma: NCT07806292 Clinical Landscape Report 2026
11 September 2026
NCT07806292 clinical landscape for Unresectable Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Elagolix Sodium in Endometrial Carcinoma: NCT07763847 Clinical Landscape Report 2026
11 September 2026
NCT07763847 clinical landscape for Endometrial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dexamethasone Sodium Phosphate in Parotid Neoplasms: NCT07812259 Clinical Landscape Report 2026
11 September 2026
NCT07812259 clinical landscape for Parotid Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Glycopyrrolate in Pulmonary Disease, Chronic Obstructive: NCT07802730 Clinical Landscape Report 2026
11 September 2026
NCT07802730 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
Temozolomide in Glioblastoma, IDH-Wildtype: NCT07758062 Clinical Landscape Report 2026
11 September 2026
NCT07758062 clinical landscape for Glioblastoma, IDH-Wildtype: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sodium Phosphate in Colonic Polyps: NCT07813013 Clinical Landscape Report 2026
11 September 2026
NCT07813013 clinical landscape for Colonic Polyps: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lenalidomide in Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: NCT07814001 Clinical Landscape Report 2026
11 September 2026
NCT07814001 clinical landscape for Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and…
9 min read
Alpha-lactalbumin-oleic acid(Azanta A/S) in Non-Muscle Invasive Bladder Neoplasms: NCT07804056 Clinical Landscape Report 2026
11 September 2026
NCT07804056 clinical landscape for Non-Muscle Invasive Bladder Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Cisplatin in Advanced biliary tract cancer: NCT07801027 Clinical Landscape Report 2026
11 September 2026
NCT07801027 clinical landscape for Advanced biliary tract cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Foralumab in Amyotrophic Lateral Sclerosis: NCT07688239 Clinical Landscape Report 2026
11 September 2026
NCT07688239 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Recombinant anti-IL-4Rα humanized monoclonal antibody (Sunshine Guojian) in Dermatitis, Atopic: NCT07767253 Clinical Landscape Report 2026
11 September 2026
NCT07767253 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.